Bioequivalence study of two azithromycin formulations in healthy subjects

Arzneimittel-Forschung/Drug Research

Volumn 59, Issue 9, 2009, Pages 471-475

  Setiawati, Effi ^a   Deniati, Siti Hawa ^a   Yunaidi, Danang Agung ^a   Handayani, Lucia Rat ^a   Harinanto, Gunawan ^a   Santoso, Iwan Dwi ^a   Sari, Asriningtyas Purnomo ^a   Rimainar, Atika ^a  

^a PT Equilab International   (Indonesia)

Author keywords

Antibiotics, macrolide; Azithromycin, bioavailability, bioequivalence, pharmacokinetics; CAS 88150 42 9; Zycin

Indexed keywords

AZITHROMYCIN; CAS 83905 01 5; UNCLASSIFIED DRUG; ZYCIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 70449671411     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296427     Document Type: Article

References (7)

1. International Conference on Harmonization, (ICH) Harmonized Tripartite Guideline for Good Clinical Practice (E6), 1996.
2. Guideline for Bioequivalence Studies. National Agency for Drug and Food Control, Jakarta, December 2004.
3. rd ed. Chicago (Illinois): The Pharmaceutical Press; 2002. p. 153.
4. th ed. New York: McGraw-Hill; 2001. p. 1252-1253
5. th ed. Whitehouse Station (NJ): Merck & Co.; 2001. p. 159.
6. Koytchev R, Ozalph Y, Erenmemisoglu A, Meer MJ, Alpan RS. Assessment of the Bioequivalence of Different Formulations Containing Azithromycin (Tablets and Suspension). Arzneimittelforschung. 2002;54(9 a):578-582 (Pubitemid 39278898)
7. Chen BM, Liang YZ, Chen X, Liu SG, Deng FL, Zhou P. Quantitative Determination of Azithromycin in Human Plasma by Liquid Chromatography-Mass Spectrometry and Its Application in a Bioequivalence Study. J Pharm Biomed Anal. 2006 Jul 3;42:480-487 (Pubitemid 44375109)